Communication with physicians


I would like however to look at the problems of diversification and communication from the international standpoint, and to deal mainly with pharmaceuticals - diversification into new therapeutic areas internationally - which is after all the major type of diversification that we as pharmaceutical market researchers are faced with.

  • PDF
  • This could also be of interest